Solid Form Analysis

Solid Form Analysis

Understanding the solid form properties of a material can significantly impact other studies. For instance, small scale batches from chiral SFC might be amorphous and dissolve readily, but process chemistry and scale-up could produce a crystalline form, affecting solubility and in vivo performance.

Polymorph Screening

Identifying the most suitable polymorph of your drug candidate is critical. It impacts the physicochemical properties such as solubility, stability, bioavailability and manufacturability of both the compound and formulation. In short, it can sometimes ‘make or break’ your formulation.

Salt and Co-crystal Screening

Salts and co-crystals offer unique opportunities for IP (intellectual property), enhance the bioavailability, taste mask and improve stability of your compound.

CMC Activities

Our Form and Formulation team offers a wealth of information to assist your Chemistry, Manufacturing, and Controls (CMC) team in advancing your molecule towards clinical trials.

Pre-Clinical Formulation & in-vivo Pharmacology Delivery

Our skilled team and state of the art laboratories have the capabilities to screen, test and develop conventional and novel enabling formulations to give your compound the best chance of success.

Early Clinical Formulation

Our objective is to design a stable, practical and robust formulation that effectively overcomes your molecule’s challenges.